Advanced search
Publication Cover
Orphan Drugs: Research and Reviews Volume 4, 2014 - Issue
Journal homepage
192
Views
3
CrossRef citations to date
0
Altmetric
Review

Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations

Georgi IskrovDepartment of Social Medicine and Public Health, Medical University of Plovdiv, Plovdiv, BulgariaCorrespondence[email protected]
&
Rumen StefanovDepartment of Social Medicine and Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria
Pages 1-9 | Published online: 09 Jan 2014

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Georgi Iskrov, Georgi Vasilev & Rumen Stefanov. (2019) What could gene therapies learn from orphan drugs’ post-regulatory approval access in the EU?. Expert Opinion on Orphan Drugs 7:9, pages 407-414.
Read now
P Lasalvia, L Prieto-Pinto, M Moreno, J Castrillón, G Romano, N Garzón-Orjuela & D Rosselli. (2019) International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research 19:4, pages 409-420.
Read now
Maria Kamusheva, Konstantin Tachkov, Guenka Petrova, Alexandra Savova & Manoela Manova. (2018) Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles. Expert Opinion on Orphan Drugs 6:2, pages 95-104.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.